Home › Aplastic Anemia › Minnesota
Aplastic Anemia clinical trials in Minnesota
3 studies for Aplastic Anemia are looking for participants at sites in Minnesota.
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
- University of Minnesota Masonic Cancer Center, Minneapolis
RecruitingPhase 2
Ages 0 to 75 · All sexes · Updated Jun 3, 2026 · NCT06412497Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
- Mayo Clinic, Rochester
RecruitingPhase 2
Ages 3 to 75 · All sexes · Updated Feb 17, 2026 · NCT06517641Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
- Masonic Cancer Center at University of Minnesota, Minneapolis
RecruitingPhase 2
Up to age 65 · All sexes · Updated Jan 30, 2026 · NCT03579875From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.